bioAffinity Technologies, Inc. (BIAFW) Net margin 2022–2025
bioAffinity Technologies, Inc. (BIAFW) net profit margin by fiscal year — reported net income divided by reported revenue.
-242.0%FY2025 · since FY2022: -169771.2% → -242.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -242.0% | -145.4 pp |
| FY2024 | -96.6% | +216.8 pp |
| FY2023 | -313.4% | +169457.8 pp |
| FY2022 | -169771.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAFW financial trends
BIAFW RevenueBIAFW Net incomeBIAFW Gross profitBIAFW Gross marginBIAFW Operating incomeBIAFW Operating marginBIAFW Operating cash flowBIAFW Free cash flowBIAFW Capital expendituresBIAFW Return on equityBIAFW Stock buybacksBIAFW Dividends paidBIAFW Total assetsBIAFW Total liabilitiesBIAFW Shareholders’ equityBIAFW overview →